#7 - UnitedHealth Group (NYSE:UNH)
UnitedHealth Group Inc. (NYSE: UNH) has been a leader in bringing AI solutions to the healthcare industry for several years. One application is the company's virtual assistant platform that it uses for data collection and personalized care.
The company also features AI in Optum, its data and technology-focused pharmacy management subsidiary. The company launched OptumIQ in 2017 to help centralize data and AI capabilities. The company's long-stated goal is for OptumIQ to play a role in predicting health conditions such as diabetes and atrial fibrillation, which can ultimately lead to lower costs.
And as an investment, UNH stock is about as rock solid as they come. The stock is up 99% in the last five years. The company also pays a reliable dividend with a current yield of 1.53%. The company has increased that dividend for 14 consecutive years. And with a conservative payout ratio of 31%, that streak is likely to keep going for some time to come.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More - Current Price
- $605.83
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 19 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $615.53 (1.6% Upside)
Is AI just a bubble? You probably hear that a lot. Apparently, many chief executive officers (CEOs) do as well. According to the Boston Consulting Group, about 90% of CEOs are waiting for AI to move beyond the hype stage. And 66% are either ambivalent or dissatisfied with their company's progress.
However, artificial intelligence has been around for nearly a decade. What many of these CEOs are referring to is generative AI. That is still in its early stages. It's also where the greatest opportunity may exist. Goldman Sachs analysts predict that investment in AI in the United States will be close to $100 billion by 2025.
MarketBeat offers a free tool that lets you compare the fundamentals of artificial intelligence stocks. You can also use it to compare companies on other factors such as analyst ratings, book value, debt, dividend, price performance, profitability, and more. You can compare up to ten stocks.
More Investing Slideshows:
